Nick Smith

Nick Smith has served as our President since August 2026 and as our Chief Financial Officer since November 2022.  He also held the role of Chief Business Officer from September 2021 to August 2026. Mr. Smith served as a member of our board of directors from July 2023 through October 2023. Prior to joining us, Mr. Smith held various roles at Aptinyx Inc., a CNS-focused biopharmaceutical company, from March 2017 until September 2021, including Vice President, Investor Relations and Corporate Development from March 2021 to September 2021; Senior Director, Corporate Development and Investor Relations from March 2019 to March 2021; and Director, Corporate Development from March 2017 to March 2019. Mr. Smith received a BA in accounting and finance from North Central College.